Drawing for NEARMEDIC

USPTO serial 79159157

NEARMEDIC

Reviewed by CopyMark Law Group

Reg. 4853285Status 404
Filing date
Status date
Registration date
Nov 17, 2015
Examiner
LE, KHANH M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NEARMEDIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Max Vern

Max Vern Amster, Rothstein & Ebenstein LLP90 Park AvenueNew York, NY 10016UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry; chemicals used in science; carbonic hydrates; raw materials, namely, animal or vegetable albumin for industrial use; raw material, namely, animal albumen for industrial use; chemicals for use in industry, namely, cellulose derivatives; chemical reagents, other than for medical or veterinary purposes; stem cells other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposesSECTION 71 - CANCELLED—
005Pharmaceutical preparations including cell-based preparations for medical purposes including stem cells for the treatment of endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; biocides; biological preparations for the prevention and treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; medicines for use by humans, namely, for use in the treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; albuminous preparations for medical purposes, namely, for use in the treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; stem cells for medical purposes; surgical dressings; diagnostic preparations for medical purposes; chemical preparations for medical purposes, namely, for use in the treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; biological tissue cultures for medical purposesSECTION 71 - CANCELLED—
010Medical apparatus and instruments for treating cardiovascular, infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases; testing apparatus for medical purposes in the field of cancer, hepatology, ophthalmology, gastroenterology, hematology, dermatology, neurology, immunology, and infectious diseases; suture materials; surgical thread; surgical implants comprised of artificial materials; surgical cell implants comprised of natural, non-living materials; surgical implants consisting primarily of artificial materials and also including biological materials; cell implants made of artificial materials; cell implants comprised of natural, non-living materials; cell implants consisting primarily of artificial materials and also including biological materialsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 29, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Aug 29, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Apr 23, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Mar 22, 2023XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Mar 22, 2023XXCRGENERIC MADRID TRANSACTION CREATED—
Feb 3, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 3, 2022C71TCANCELLED SECTION 71—
Nov 17, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 5, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 23, 2016XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Feb 23, 2016XXCRGENERIC MADRID TRANSACTION CREATED—
Feb 17, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 17, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 1, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 1, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 28, 2015GPNXNOTIFICATION PROCESSED BY IB—
Aug 12, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 12, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 12, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 28, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 27, 2015ALIEASSIGNED TO LIE—
Jul 16, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 16, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 15, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 1, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 1, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 1, 2015ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Apr 30, 2015GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 30, 2015GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 30, 2015CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 10, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 10, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 10, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 10, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 20, 2015RFNTREFUSAL PROCESSED BY IB—
Feb 4, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 4, 2015RFRRREFUSAL PROCESSED BY MPU—
Feb 3, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 3, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 2, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 30, 2015DOCKASSIGNED TO EXAMINER—
Jan 30, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 29, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance